126 related articles for article (PubMed ID: 11506957)
1. Compliance with follow-up and prognosis among patients with thin melanomas.
Kittler H; Weitzdorfer R; Pehamberger H; Wolff K; Binder M
Eur J Cancer; 2001 Aug; 37(12):1504-9. PubMed ID: 11506957
[TBL] [Abstract][Full Text] [Related]
2. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
3. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
4. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
Machet L; Nemeth-Normand F; Giraudeau B; Perrinaud A; Tiguemounine J; Ayoub J; Alison D; Vaillant L; Lorette G
Br J Dermatol; 2005 Jan; 152(1):66-70. PubMed ID: 15656802
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
6. A rational approach to the follow-up of melanoma patients.
Garbe C
Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
[TBL] [Abstract][Full Text] [Related]
11. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
Starz H; Balda BR
Int J Cancer; 2007 Aug; 121(3):689-93. PubMed ID: 17397029
[TBL] [Abstract][Full Text] [Related]
12. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
14. [Tumour regression is not predictive for higher risk of sentinel node involvement in thin melanomas (Breslow thickness < or = 1 mm)].
Kramkimel N; Maubec E; Boitier F; Cavalcanti A; Beldi M; Mamelle G; Kolb F; Duvillard P; Avril MF
Ann Dermatol Venereol; 2010 Apr; 137(4):276-80. PubMed ID: 20417360
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with melanoma and histologically negative sentinel lymph nodes.
Gadd MA; Cosimi AB; Yu J; Duncan LM; Yu L; Flotte TJ; Souba WW; Ott MJ; Wong LS; Sober AJ; Mihm MC; Haluska FG; Tanabe KK
Arch Surg; 1999 Apr; 134(4):381-7. PubMed ID: 10199310
[TBL] [Abstract][Full Text] [Related]
16. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
17. Surveillance and follow-up examinations in cutaneous melanoma.
Garbe C; Schadendorf D
Onkologie; 2003 Jun; 26(3):241-6. PubMed ID: 12845208
[TBL] [Abstract][Full Text] [Related]
18. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study.
Blum A; Schmid-Wendtner MH; Mauss-Kiefer V; Eberle JY; Kuchelmeister C; Dill-Müller D
Dermatology; 2006; 212(1):47-52. PubMed ID: 16319474
[TBL] [Abstract][Full Text] [Related]
20. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]